12280sek
0,6 %
Date:2026-10-15Time:18:00:00Latest report:Q2-2026List:Mid CapTicker:BIOG B
Market Cap:12 423 msekEnterprise Value:11 976 msekNet Sales:1 581 msekEarnings:347,2 msekEmployees:0ISIN:SE0017769995
Ratios
10-year key figure history for BioGaia turnover, profit, dividend, equity, PE and PB.
Stockprice
Price movement for BioGaia with index and moving average MA50 and MA200.
Stockprice:122,80
MA50:113,52
MA200:115,74
Price/MA200:6,1 %
RSI (14):73,1
Price/MA50:8,2 %
Description
BioGaia is a biotechnology company operating in the pharmaceutical industry and focuses on the development, manufacturing and distribution of probiotics for health and well-being. The company's products are aimed at individuals and healthcare institutions. The business is global with a primary presence in Europe, North America and Asia. BioGaia was founded in 1990 and is headquartered in Stockholm.